Sato, Toshihiro, Masamitsu Maekawa, Nariyasu Mano, Takaaki Abe, and Hiroaki Yamaguchi. “Role of OATP4C1 in Renal Handling of Remdesivir and Its Nucleoside Analog GS-441524: The First Approved Drug for Patients With COVID-19”. Journal of Pharmacy & Pharmaceutical Sciences 24 (May 15, 2021): 227–236. Accessed April 15, 2025. https://journals.library.ualberta.ca/jpps/index.php/JPPS/article/view/31813.